Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-051305

Director sold 4,198 shares at $3.16 ($13,266)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Curet Myriam Director 2022-09-23 Sale −4,198 $3.16 $13,266 31,777 D: show line 1 in the form
Open-market sales · 4,198 sh · avg $3.16 · $13,266
Loading xslF345X03/doc4.xml…